|4Jun 18, 8:17 PM ET

Marquet Magda 4

4 · ANAPTYSBIO, INC · Filed Jun 18, 2024

Insider Transaction Report

Form 4
Period: 2024-06-15
Transactions
  • Exercise/Conversion

    Common Stock

    2024-06-15+3,9003,900 total
  • Exercise/Conversion

    Restricted Stock Unit

    2024-06-153,9000 total
    Common Stock (3,900 underlying)
Footnotes (2)
  • [F1]Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
  • [F2]The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2024 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Documents

1 file
  • 4
    form4-06192024_120639.xmlPrimary